A Phase II Study of Erlotinib in Patients with Previously Treated Non-Small Cell Lung Cancer
Advances in Lung Cancer · 2014
DOI: 10.4236/alc.2014.31002 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advances in Lung Cancer, 2014. Verfasst von Tetsuya Kubota und 11 weiteren Autor:innen. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Kubota, T., Okano, Y., Sakai, M., Yamane, T., Shiota, N., Ohnishi, H., Machida, H., Hatakeyama, N., Takeuchi, E., Urata, T., Ogushi, F., & Yokoyama, A. (2014). A Phase II Study of Erlotinib in Patients with Previously Treated Non-Small Cell Lung Cancer. Advances in Lung Cancer. https://doi.org/10.4236/alc.2014.31002
Vancouver
Kubota T, Okano Y, Sakai M, Yamane T, Shiota N, Ohnishi H, et al. A Phase II Study of Erlotinib in Patients with Previously Treated Non-Small Cell Lung Cancer. Advances in Lung Cancer. 2014. doi:10.4236/alc.2014.31002
BibTeX
@article{Kubota2014,
author = {Kubota, Tetsuya and Okano, Yoshio and Sakai, Mizu and Yamane, Takashi and Shiota, Naoki and Ohnishi, Hiroshi and Machida, Hisanori and Hatakeyama, Nobuo and Takeuchi, Eiji and Urata, Tomoyuki and Ogushi, Fumitaka and Yokoyama, Akihito},
title = {A Phase II Study of Erlotinib in Patients with Previously Treated Non-Small Cell Lung Cancer},
journal = {Advances in Lung Cancer},
year = {2014},
doi = {10.4236/alc.2014.31002}
}
EUVIMED